Skip to main content

News

desc

Dr. Peter Ellmark was appointed Assoc. Prof. (docent) in Immunotechnology.     

desc

Prof. Mats Ohlin was awarded a grant of 4.7 MSEK for an antibody engineering project from the Swedish National Space Board.

desc

Dr. Mattias Levin of the Dept. of Immunotechnology today won the prize for best poster in the Allergic immune responses session at the 2014 European Academy of Allergy and Clinical Immunology Congress in Copenhagen. The titel of his work was Genetically restricted local IgE repertoires from nasal tissue of allergic donors target multiple epitopes [...]

desc

The Department was granted support for several research projects by the Swedish Research Council:Carl Borrebaeck: Cellular basis for allergy: regulation of the allergic immune response by dendritic cells Carl Borrebaeck: Global proteome analysis using context independent motif specific antibodies and micoarraysMats Ohlin: Allergen-specific [...]

desc

Dr. Kristina Lundberg of the Dept. of Immunotechnology today won the prize for best poster in the Immunotherapies & miscellaneous session at the 2014 European Academy of Allergy and Clinical Immunology Congress in Copenhagen. The titel of her work was Expression of allergy-associated C-type lectin receptors by DC subsets is modified by [...]

desc

Johan Teleman of the Dept. of Immunotechnology was awarded a price for best MSc thesis in 2011 from the Bo Rydin Foundation for Scientific Research.

desc

Sara Ek was appointed professor of Immunotechnology at Lund University. Congratulations!    

desc

The Department was granted a 2 year postdoctoral grant for Dr. Helena Persson from the Lund School of Technology.  

desc

Prof Sara Ek of the Dept. of Immunotechnology was awarded a grant from Cancerfonden for a project entitled Molekylära undersökningar av primära, resistenta och återfallstumörer hos patienter med mantelcellslymfom samt utveckling av kliniska verktyg för behandlingsval.   

desc

Assoc. Prof. Sara Ek was awarded a grant (1 MSEK) from Stiftelsen Olle Engkvist Byggmästare for a project entitled "Development of therapeutic modalities based on novel transcription factors, including Sox 11".  

Page Manager: jana.hagman@immun.lth.se | 2022-11-21